Neuracle Completed 60 million Yuan A Round of Financing, Led by Tsinghua Holdings Capital

According to Pedaily，Neuracle announced the completion of Series A financing of 60 million yuan. This round of investment is led by Tsinghua Holdings Capital, followed by Zhongguancun Development Sail Fund, Zhongguancun Development Frontier Fund, Baidu Ventures, and Cowin Venture, an existing investor in Pre-A round. So far, Neuracle has completed three rounds of financing, with the total financing scale exceeding 100 million yuan. 

Huang Xiaoshan, general manager of Neuracle, said that the financing funds were mainly used to accelerate the research and development of clinical products and promote the implementation of products in the fields of minimally invasive implant feedback therapy and active rehabilitation of brain intelligence.

Neuracle is a well-known enterprise in the field of neuroscience in China. It relies on Tsinghua University's independent innovation and international leading "brain-machine interface" technology, and are committed to innovative research in the fields of neuroscience, psychology, neuroengineering, etc., providing professional and complete solutions for the diagnosis, treatment, and rehabilitation of program about clinical neurological diseases. Their products cover a wide range of fields including clinical medicine, neuroscience, psychology, management marketing, etc., and take the lead in undertaking the National Twelfth Five-Year Science and Technology Support Program. 

Tsinghua Holdings Capital (THC) is a Beijing-based private equity investment fund with a focus on high-end technology, industrials, and healthcare. The fund has grown steadily since its inception in 2007, focusing on discovering and investing in China's leading enterprises in high growth business sectors such as industrials, TMT and entertainment. With over RMB 10billion in assets under management, Tsinghua Holdings Capital has a proven record of delivering strong returns through its specialized funds. 

Zhongguancun Development Sail Industrial Investment Fund  (Zhongguancun Development Sail Fund) is a high-tech enterprise equity investment platform established by Zhongguancun Development Group, mainly focused on biological medicine, information technology, new energy, new materials, and intelligent manufacturing. 

Zhongguancun Development Frontier Enterprise Investment Fund (Zhongguancun Development Frontier Fund) mainly provides non-securities business investment, equity investment, investment management and consulting service.

BV was founded as a result of the massive driving force AI represents. It invests in deep tech companies pushing the frontiers that enable artificial intelligence as well as companies building applications that were previously impossible without AI. 

BV is a financial investor focusing on the Seed, Series A, and Series B of companies across China, North America & Europe, with teams in all three geographies.

Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies who graduated from our angel investment portfolio. Cowin’s business network covers China and the USA. We have offices in Suzhou, Nanjing, Shanghai, Beijing, and Hong Kong.